Autoantibodies targeting the endogenous interleukin 1 receptor antagonist were evaluated for their prevalence and clinical role in patients with inflammatory recurrent pericarditis.
What is the prevalence and role of autoantibodies targeting the endogenous interleukin 1 (IL-1) receptor antagonist in patients with recurrent pericarditis with an inflammatory phenotype?
This study investigates the presence of IL-1 receptor antagonist autoantibodies in idiopathic recurrent pericarditis, which may provide insights into its underlying pathophysiology.
Absolute Event Rate: 0% vs 0%
This cohort study investigates the prevalence and role of autoantibodies targeting the endogenous interleukin 1 (IL-1) receptor antagonist in patients with recurrent pericarditis with an inflammatory phenotype.
Wu et al. (Thu,) reported a other. Autoantibodies targeting the endogenous interleukin 1 receptor antagonist were evaluated for their prevalence and clinical role in patients with inflammatory recurrent pericarditis.